🇺🇸 FDA
Patent

US 9623040

Immunomodulation by controlling expression levels of microRNAs in dendritic cells

granted A61KA61K2035/122A61K2239/31

Quick answer

US patent 9623040 (Immunomodulation by controlling expression levels of microRNAs in dendritic cells) held by The Regents of the University of California expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2035/122, A61K2239/31, A61K2239/38, A61K31/7105